Edition:
United Kingdom

People: Chimerix Inc (CMRX.OQ)

CMRX.OQ on NASDAQ Stock Exchange Global Market

2.20USD
23 Aug 2019
Change (% chg)

$-0.15 (-6.38%)
Prev Close
$2.35
Open
$2.35
Day's High
$2.47
Day's Low
$2.18
Volume
127,992
Avg. Vol
106,303
52-wk High
$4.39
52-wk Low
$1.75

Knight-Trent, Heather 

Dr. Heather Knight-Trent is Vice President - Regulatory Affairs of the Company. Dr. Knight-Trent was previously executive director of regulatory affairs at Hurley Consulting Associates, where she was responsible for regulatory strategy and implementation for multiple clients. She was previously at Bristol Myers Squibb for ten years in roles both in the U.S. and Europe, most recently as the director of global regulatory, safety and biometrics business operations. In this role Dr. Knight-Trent supported the vice presidents of global regulatory strategy for all therapeutic areas on resourcing, budget, group capabilities and continuous improvement projects. She also held positions in regulatory affairs at Zymogenetics (acquired by Bristol-Myers Squibb) in Seattle, Washington and at Hoffmann-La Roche, Inc., in Nutley, New Jersey. Dr. Knight-Trent holds a bachelor's degree in biology and a doctor of pharmacy degree from West Virginia University. In 2000 and 2001, she was a Rutgers Industrial Pharmacy Post-Doctoral Fellow with Hoffmann-La Roche, Inc., and FDA CDER's oncology division. Dr. Knight-Trent is a registered pharmacist in West Virginia and she is a member of the West Virginia University School of Pharmacy Leadership Council.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --